Literature DB >> 11230273

Mortality after coronary artery occlusion in different models of cardiac hypertrophy in rats.

F H Leenen1, B Yuan.   

Abstract

Chronic treatment with minoxidil induces cardiac trophic and sympathetic responses, which may increase the propensity for lethal arrhythmias. To test this hypothesis, acute coronary artery occlusion was performed in conscious normotensive rats treated for 2 or 5 weeks with minoxidil with the use of a 2-stage approach to cause a myocardial infarction. For comparison, rats with aortocaval (A-V) shunts and spontaneously hypertensive rats (SHR) were studied. Minoxidil increased left ventricular and right ventricular weights by 15% to 20%, and the A-V shunt increased these weights by 30% to 40%. In SHR, left ventricular weight was increased by 50%, and right ventricular weight was increased by 25%. In rats treated with minoxidil for 5 weeks, coronary artery occlusion caused a rapid and marked mortality, and 4 hours after myocardial infarction, only 18% of these rats were alive versus 61% of the control rats. In rats with the A-V shunt, coronary artery occlusion was also associated with increased mortality, and after 6 hours, 33% were still alive compared with 59% of the control rats. In contrast, SHR with marked hypertension and cardiac hypertrophy showed only a minor increase in mortality (survival rates were 53% versus 60% in SHR versus Wistar-Kyoto rats, respectively). Mortality was preceded by high arrhythmia scores, and ventricular fibrillation was the cause of death. Discontinuation of minoxidil for 1 week, sympathetic blockade with nadolol or clonidine, or blockade of the renin-angiotensin system with enalapril or losartan did not improve minoxidil-induced excess mortality. We conclude that ventricular stretch and other mechanisms (eg, cardiac vagal activity) in rats appear to be more potent than hypertension-induced left ventricular hypertrophy in predisposing for lethal arrhythmias in the setting of acute ischemia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11230273     DOI: 10.1161/01.hyp.37.2.209

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  7 in total

1.  Protective effects of betaglucin on myocardial tissue during myocardial infarction in rats and dogs.

Authors:  Jiao Qian; Ai-jun Liu; Wei Zhang; Zhi-peng Wen; Li-li Lin; Jing-hang Wang; Ding-feng Su; Jian-guo Liu
Journal:  Acta Pharmacol Sin       Date:  2009-07-13       Impact factor: 6.150

Review 2.  Granulocyte colony-stimulating factor for ischemic heart failure: should we use it?

Authors:  Marcelo Perim Baldo; Sérgio Lamêgo Rodrigues; José Geraldo Mill
Journal:  Heart Fail Rev       Date:  2010-11       Impact factor: 4.214

3.  CD36 overexpression predisposes to arrhythmias but reduces infarct size in spontaneously hypertensive rats: gene expression profile analysis.

Authors:  Jan Neckář; Jan Šilhavy; Václav Zídek; Vladimír Landa; Petr Mlejnek; Miroslava Šimáková; J G Seidman; Christine Seidman; Ludmila Kazdová; Martina Klevstig; František Novák; Marek Vecka; František Papoušek; Josef Houštěk; Zdeněk Drahota; Theodore W Kurtz; František Kolář; Michal Pravenec
Journal:  Physiol Genomics       Date:  2011-11-29       Impact factor: 3.107

4.  Echocardiographic assessment of myocardial infarction: comparison of a rat model in two strains.

Authors:  R Esmaeili; A Sadeghpour; A Darbandi-Azar; K Majidzadeh-A; A Vajhi; M Sadeghizadeh
Journal:  Iran J Vet Res       Date:  2017       Impact factor: 1.376

5.  Transgenic rescue of defective Cd36 enhances myocardial adenylyl cyclase signaling in spontaneously hypertensive rats.

Authors:  Martina Klevstig; Dmitry Manakov; Dita Kasparova; Iveta Brabcova; Frantisek Papousek; Jitka Zurmanova; Vaclav Zidek; Jan Silhavy; Jan Neckar; Michal Pravenec; Frantisek Kolar; Olga Novakova; Jiri Novotny
Journal:  Pflugers Arch       Date:  2013-05-01       Impact factor: 3.657

6.  Echocardiographic validation of pulmonary hypertension due to heart failure with reduced ejection fraction in mice.

Authors:  Nour R Dayeh; Jean-Claude Tardif; Yanfen Shi; Mégane Tanguay; Jonathan Ledoux; Jocelyn Dupuis
Journal:  Sci Rep       Date:  2018-01-22       Impact factor: 4.379

7.  Exploring the mechanism of Shengmai Yin for coronary heart disease based on systematic pharmacology and chemoinformatics.

Authors:  Yan Jiang; Qi He; Tianqing Zhang; Wang Xiang; Zhiyong Long; Shiwei Wu
Journal:  Biosci Rep       Date:  2020-06-26       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.